van Houte Hans
SEC insider (Form 3/4/5 filer). CIK 0001817217. Chief Financial Officer at Nurix Therapeutics, Inc. (NRIX). 51 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in BRISBANE, CA.
Companies van Houte Hans has filed insider reports for
- Nurix Therapeutics, Inc. (NRIX): Officer, Chief Financial Officer
van Houte Hans
CIK: 0001817217
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nurix Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (51 total)
- Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect3K shares at avg. $24.65$73K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect1.8K shares at avg. $23.89$43K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect2.9K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect2.8K shares at avg. $23.38$67K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect3.6K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect3.8K shares- - May 5, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect13.5K shares at avg. $16.58$223K - May 5, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect582 shares at avg. $17.18$10K - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect2K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect3.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 2,967 | $24.65 | $73,129 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 1,794 | $23.89 | $42,861 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 2,858 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 2,845 | $23.38 | $66,524 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 3,572 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 3,750 | - | $0 | Direct |
| May 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 13,473 | $16.58 | $223,323 | Direct |
| May 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 582 | $17.18 | $9,996 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 2,000 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 3,750 | - | $0 | Direct |
1-10 of 51 transactions